DCPHDeciphera Pharmaceuticals, ...

Nasdaq deciphera.com


$ 25.51 $ 0.00 (0 %)    

Tuesday, 28-May-2024 15:59:54 EDT
QQQ $ 454.82 $ 1.73 (0.38 %)
DIA $ 398.57 $ -2.04 (-0.52 %)
SPY $ 530.36 $ 0.37 (0.07 %)
TLT $ 91.26 $ -1.31 (-1.43 %)
GLD $ 225.37 $ 2.27 (1.05 %)
$ 25.51
$ 25.53
$ 25.51 x 1,929
$ 0.00 x 0
$ 25.51 - $ 25.53
$ 9.90 - $ 25.55
1,089,389
na
2.23B
$ 0.79
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-10-2024 03-31-2024 10-Q
2 02-07-2024 12-31-2023 10-K
3 10-30-2023 09-30-2023 10-Q
4 08-09-2023 06-30-2023 10-Q
5 05-03-2023 03-31-2023 10-Q
6 02-07-2023 12-31-2022 10-K
7 11-03-2022 09-30-2022 10-Q
8 08-04-2022 06-30-2022 10-Q
9 05-04-2022 03-31-2022 10-Q
10 02-08-2022 12-31-2021 10-K
11 11-02-2021 09-30-2021 10-Q
12 08-03-2021 06-30-2021 10-Q
13 05-04-2021 03-31-2021 10-Q
14 02-09-2021 12-31-2020 10-K
15 11-05-2020 09-30-2020 10-Q
16 08-04-2020 06-30-2020 10-Q
17 05-05-2020 03-31-2020 10-Q
18 03-09-2020 12-31-2019 10-K
19 11-04-2019 09-30-2019 10-Q
20 08-02-2019 06-30-2019 10-Q
21 05-09-2019 03-31-2019 10-Q
22 03-14-2019 12-31-2018 10-K
23 11-08-2018 09-30-2018 10-Q
24 08-07-2018 06-30-2018 10-Q
25 05-08-2018 03-31-2018 10-Q
26 03-28-2018 12-31-2017 10-K
27 11-14-2017 09-30-2017 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 guggenheim-downgrades-deciphera-pharmaceuticals-to-neutral

Guggenheim analyst Michael Schmidt downgrades Deciphera Pharmaceuticals (NASDAQ:DCPH) from Buy to Neutral.

 jmp-securities-downgrades-deciphera-pharmaceuticals-to-market-perform

JMP Securities analyst Reni Benjamin downgrades Deciphera Pharmaceuticals (NASDAQ:DCPH) from Market Outperform to Market Per...

 barclays-upgrades-deciphera-pharmaceuticals-to-equal-weight-raises-price-target-to-26

Barclays analyst Peter Lawson upgrades Deciphera Pharmaceuticals (NASDAQ:DCPH) from Underweight to Equal-Weight and raises t...

 us-stocks-kick-off-the-week-in-the-green-tesla-rockets-on-chinas-fsd-approval-yen-rallies-whats-driving-markets-monday

U.S. stocks kicked off the week on a positive note, with all major averages edging higher in anticipation of significant events...

 why-is-cancer-focused-deciphera-pharmaceuticals-stock-skyrocketing-on-monday

ONO Pharmaceutical to acquire Deciphera Pharmaceuticals for $2.4B in cash. Deciphera brings specialized R&D in kinase drug ...

 jonestrading-downgrades-deciphera-pharmaceuticals-to-hold-announces-256-price-target

JonesTrading analyst Soumit Roy downgrades Deciphera Pharmaceuticals (NASDAQ:DCPH) from Buy to Hold and announces $25.6 pric...

 jefferies-downgrades-deciphera-pharmaceuticals-to-hold-lowers-price-target-to-256

Jefferies analyst Eun Yang downgrades Deciphera Pharmaceuticals (NASDAQ:DCPH) from Buy to Hold and lowers the price target f...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION